Methylphenidate

Amphetamine (piperidine derivative).

NICE 31 Oct 2000

Indications

AD/HD (Attention Deficit/Hyperactivity Disorder), Hyperkinetic disorder.
By paediatrician/child psychiatrist with expertise in ADHD, HKD only, in the context of a comrehensive treatment programme.
Narcolepsy.

Mechanism

Adverse effects

Growth retardation, insomnia, restlessness, irritability, night terrors.

Monitoring

Discontinue if no effect after 1/12. When child is stable, methylphenidate should be discontinued and child's progress assessed. Usually finally discontinued during/after puberty.